Serum Metabolites Associated with Brain Amyloid Beta Deposition, Cognitive Dysfunction, and Alzheimer’s Disease Progression

Author:

Nho KwangsikORCID,Kueider-Paisley AlexandraORCID,Arnold MatthiasORCID,MahmoudianDehkordi SiamakORCID,Risacher Shannon L.ORCID,Louie Gregory,Blach ColetteORCID,Baillie RebeccaORCID,Han Xianlin,Kastenmüeller GabiORCID,Doraiswamy P. Murali,Kaddurah-Daouk RimaORCID,Saykin Andrew J.ORCID,

Abstract

AbstractRATIONALEMetabolomics in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort provides a powerful tool for mapping biochemical changes in AD, and a unique opportunity to learn about the association between circulating blood metabolites and brain amyloid-β deposition in AD.OBJECTIVESWe examined 140 serum metabolites and their associations with brain amyloid-β deposition, cognition, and conversion from mild cognitive impairment (MCI) to AD.FINDINGSSerum-based targeted metabolite levels were measured in 1,531 ADNI participants. We performed association analysis of metabolites with brain amyloid-β deposition measured from [18F] Florbetapir PET scans. We identified nine metabolites as significantly associated with amyloid-β deposition after FDR-based multiple comparison correction. Higher levels of one acylcarnitine (C3; propionylcarnitine) and one biogenic amine (kynurenine) were associated with decreased amyloid-β accumulation. However, higher levels of seven phosphatidylcholines (PC) were associated with increased amyloid deposition. In addition, PC ae C44:4 was significantly associated with cognition and conversion from MCI to AD dementia.CONCLUSIONPerturbations in PC and acylcarnitine metabolism may play a role in features intrinsic to AD including amyloid-β deposition and cognitive performance.

Publisher

Cold Spring Harbor Laboratory

Reference67 articles.

1. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

2. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer’s disease;Journal of proteomics.,2014

3. Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS);Alzheimer’s & dementia (Amsterdam, Netherlands).,2016

4. The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer’s disease and mild cognitive impairment;Alzheimer’s & dementia (Amsterdam, Netherlands).,2015

5. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study;PLoS medicine.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3